The store will not work correctly when cookies are disabled.
(2R,3S,4S,6R)-2-(hydroxymethyl)-6-undecylpiperidine-3,4-diol
ID: ALA207359
PubChem CID: 15604793
Max Phase: Preclinical
Molecular Formula: C17H35NO3
Molecular Weight: 301.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCCCCCC[C@@H]1C[C@H](O)[C@@H](O)[C@@H](CO)N1
Standard InChI: InChI=1S/C17H35NO3/c1-2-3-4-5-6-7-8-9-10-11-14-12-16(20)17(21)15(13-19)18-14/h14-21H,2-13H2,1H3/t14-,15-,16+,17+/m1/s1
Standard InChI Key: CFTMRMOTWVSRCS-NCOADZHNSA-N
Molfile:
RDKit 2D
21 21 0 0 1 0 0 0 0 0999 V2000
5.0304 -4.6079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7442 -4.1944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4581 -4.6040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1720 -4.1905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8859 -4.6001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5997 -4.1866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3136 -4.5962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0275 -4.1827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7413 -4.5923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4552 -4.1788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1691 -4.5884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8848 -3.3470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8848 -4.1740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5982 -4.5836 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3117 -4.1740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3117 -3.3470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5982 -2.9296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0274 -4.5884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0291 -2.9355 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5982 -2.1026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.0264 -5.4154 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10 11 1 0
12 13 1 0
5 6 1 0
1 2 1 0
6 7 1 0
3 4 1 0
7 8 1 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
8 9 1 0
15 18 1 1
4 5 1 0
16 19 1 1
9 10 1 0
17 20 1 6
13 11 1 6
2 3 1 0
18 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 301.47 | Molecular Weight (Monoisotopic): 301.2617 | AlogP: 2.35 | #Rotatable Bonds: 11 |
Polar Surface Area: 72.72 | Molecular Species: BASE | HBA: 4 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.43 | CX Basic pKa: 8.91 | CX LogP: 2.74 | CX LogD: 1.23 |
Aromatic Rings: ┄ | Heavy Atoms: 21 | QED Weighted: 0.44 | Np Likeness Score: 1.85 |
References
1. Pearson MS, Saad RO, Dintinger T, Amri H, Mathé-Allainmat M, Lebreton J.. (2006) Flexible synthesis and biological evaluation of novel 5-deoxyadenophorine analogues., 16 (12): [PMID:16603357] [10.1016/j.bmcl.2006.03.035] |